Lexaria Bioscience (LEXX) Institutional Ownership → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free LEXX Stock Alerts $3.55 -0.05 (-1.39%) (As of 05/10/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Lexaria Bioscience (NASDAQ:LEXX)CurrentInstitutional OwnershipPercentage13.06%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$1.51MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$40.44K Get LEXX Insider Trade Alerts Want to know when executives and insiders are buying or selling Lexaria Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LEXX Institutional Buying and Selling by Quarter Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. Lexaria Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/9/2024 Welch Group LLC24,000$87K0.0%N/A0.194% 2/14/2024Invenomic Capital Management LP731,981$915K0.0%-4.2%7.011% 2/8/2024 Cowen AND Company LLC256,327$320K0.1%N/A2.455% 11/15/2023Armistice Capital LLC889,272$889K0.0%N/A10.992% 8/14/2023Invenomic Capital Management LP766,573$560K0.0%+62.0%9.476% 8/8/2022 Merit Financial Group LLC21,267$63K0.0%N/A0.357% 2/11/2022Invenomic Capital Management LP359,113$1.45M0.3%+1.9%6.034% 11/15/2021MD Financial Management Inc.407,687$2.55M0.1%+15,078.2%7.988% 8/16/2021Invenomic Capital Management LP317,110$2.22M0.5%+7.1%6.213% 8/13/2021Renaissance Technologies LLC17,200$120K0.0%N/A0.337% 8/13/2021Geode Capital Management LLC50,385$352K0.0%N/A0.987% 8/13/2021Vanguard Group Inc.25,976$182K0.0%N/A0.509% 5/21/2021Citadel Advisors LLC14,915$84K0.0%N/A0.292% 5/18/2021Citadel Advisors LLC14,915$84K0.0%N/A0.292% (Data available from 1/1/2016 forward) LEXX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LEXX shares? During the previous two years, the following institutional investors and hedge funds held shares of Lexaria Bioscience shares: Invenomic Capital Management LP ($915K), Armistice Capital LLC ($889K), Cowen AND Company LLC ($320K), and Welch Group LLC ($87K), Merit Financial Group LLC ($63K).Learn more on LEXX's institutional investors. What percentage of Lexaria Bioscience stock is owned by institutional investors? 13.06% of Lexaria Bioscience stock is owned by institutional investors. Learn more on LEXX's institutional investor holdings. Which institutional investors have been buying Lexaria Bioscience stock? The following institutional investors have purchased Lexaria Bioscience stock in the last 24 months: Armistice Capital LLC ($889.27K), Invenomic Capital Management LP ($293.47K), Cowen AND Company LLC ($256.33K), Welch Group LLC ($24K), and Merit Financial Group LLC ($21.27K). How much institutional buying is happening at Lexaria Bioscience? Institutional investors have bought a total of 1,484,336 shares in the last 24 months. This purchase volume represents approximately $1.57M in transactions. Which Lexaria Bioscience major shareholders have been selling company stock? The following institutional investors have sold Lexaria Bioscience stock in the last 24 months: Invenomic Capital Management LP ($32.35K). How much institutional selling is happening at Lexaria Bioscience? Institutional investors have sold a total of 32,351 shares in the last 24 months. This volume of shares sold represents approximately $40.44K in transactions. Related Companies: UNCY Institutional Ownership CARA Institutional Ownership XLO Institutional Ownership APLM Institutional Ownership PMN Institutional Ownership IMRX Institutional Ownership BOLT Institutional Ownership RMTI Institutional Ownership MRKR Institutional Ownership EYEN Institutional Ownership This page (NASDAQ:LEXX) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking: One AI startup's revenue could surge 4,735%Manward PressElon to Transform U.S. Economy? Porter & CompanyMissed NVDA? Buy this AI stock NOWChaikin Analytics[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingGlobal crypto currency reset (41 major banks signed up)Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
